Rheumatoid Arthritis Saudi Database (RASD): Disease Characteristics and Remission Rates in a Tertiary Care Center

被引:17
作者
Almoallim, Hani [1 ,2 ,3 ]
Hassan, Rola [2 ,3 ]
Cheikh, Mohamed [2 ,3 ]
Faruqui, Hanan [2 ]
Alquraa, Reem [2 ]
Eissa, Ayman [2 ]
Alhazmi, Aous [3 ]
Alsolaimani, Roaa [2 ,4 ]
Janoudi, Nahed [2 ]
机构
[1] Umm Alqura Univ, Fac Med, Dept Med, Mecca, Saudi Arabia
[2] Doctor Soliman Fakeeh Hosp, Internal Med Dept, Jeddah, Saudi Arabia
[3] Umm Alqura Univ, Alzaidi Chair Res Rheumat Dis, Mecca, Saudi Arabia
[4] King Abdulaziz Univ, Fac Med, Dept Med, Jeddah, Saudi Arabia
来源
OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS | 2020年 / 12卷
关键词
rheumatoid arthritis; disease-modifying antirheumatic drugs; biologics; TNF blockers; registry; remission rates; TUMOR-NECROSIS-FACTOR; ANTI-TNF THERAPY; BIOLOGICS REGISTER; CLINICAL REMISSION; BRITISH SOCIETY; RISK; TUBERCULOSIS; LYMPHOMA; ETANERCEPT; PREDICTORS;
D O I
10.2147/OARRR.S260426
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: National Registries are essential to direct current practice. Rheumatoid arthritis (RA) registries in the middle east and North Africa remain scarcely represented. Objective: To describe a population of Saudi RA patients and to compare the findings to internationally reported data. Methods: This is an observational study that was conducted at Doctor Soliman Fakeeh Hospital (DSFH) in Saudi Arabia. The study ran from 2014 to 2018 using a pool of 433 patients. Inclusion criteria included adults older than 18 years of age who fulfilled the 2010 American College of Rheumatology criteria for the diagnosis of RA and who were also regular visitors in our rheumatology clinics. Data were collected directly from patients and entered in a specially designed program. Results: At initial presentation, 45.5% had demonstrated active disease (moderate or high disease activity) based on DAS-28-CRP scores, while 54.5% were in low disease activity or remission. The remission rates after 1 year had increased to 79.6% (345 patients), while 9.7% (42 patients) and 10.6% (46 patients) had low disease activity and moderate disease activity, respectively. It was also found that the female gender, higher Health Assessment Questionnaire-Disability Index (HAQ-DI) and longer lag1/lag2 periods were associated with higher disease activity in our population. Conclusion: We detected higher remission rates at 1 year of follow-up. This could be attributed to many factors, including good referral systems with easier access to biologics. We aim to expand this registry to the national level.
引用
收藏
页码:139 / 145
页数:7
相关论文
共 37 条
[1]   Epidemiology of adult rheumatoid arthritis [J].
Alamanos, Y ;
Drosos, AA .
AUTOIMMUNITY REVIEWS, 2005, 4 (03) :130-136
[2]  
Alkadi Amjad, 2017, Int J Health Sci (Qassim), V11, P41
[3]  
Almoallim H, 2017, OPEN ACCESS RHEUMATO, V9, P81, DOI 10.2147/OARRR.S134780
[4]  
Barhamain AS, 2017, OPEN ACCESS RHEUMATO, V9, P139, DOI 10.2147/OARRR.S138830
[5]   The Effect of Different Remission Definitions on Identification of Predictors of Both Point and Sustained Remission in Rheumatoid Arthritis Treated with Anti-TNF Therapy [J].
Barnabe, Cheryl ;
Homik, Joanne ;
Barr, Susan G. ;
Martin, Liam ;
Maksymowych, Walter P. .
JOURNAL OF RHEUMATOLOGY, 2014, 41 (08) :1607-1613
[6]   Tumor necrosis factor antagonist therapy and lymphoma development - Twenty-six cases reported to the Food and Drug Administration [J].
Brown, SL ;
Greene, MH ;
Gershon, SK ;
Edwards, ET ;
Braun, MM .
ARTHRITIS AND RHEUMATISM, 2002, 46 (12) :3151-3158
[7]   The good EULAR response at the first year is strongly predictive of clinical remission in rheumatoid arthritis: results from the TARAC cohort [J].
Darawankul, Budsakorn ;
Chaiamnuay, Sumapa ;
Pakchotanon, Rattapol ;
Asavatanabodee, Paijit ;
Narongroeknawin, Pongthorn .
CLINICAL RHEUMATOLOGY, 2015, 34 (01) :43-49
[8]   Epidemiology and treatment patterns of rheumatoid arthritis in a large cohort of Arab patients (vol 13, e0208240, 2018) [J].
Dargham, Soha R. ;
Zahirovic, Sumeja ;
Hammoudeh, Mohammed ;
Al Emadi, Samar ;
Masri, Basel K. ;
Halabi, Hussein ;
Badsha, Humeira ;
Uthman, Imad ;
Mahfoud, Ziyad R. ;
Ashour, Hadil ;
El Haq, Wissam Gad ;
Bayoumy, Karim ;
Kapiri, Marianthi ;
Saxena, Richa ;
Plenge, Robert M. ;
Kazkaz, Layla ;
Arayssi, Thurayya .
PLOS ONE, 2019, 14 (03)
[9]   Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR) [J].
Dixon, W. G. ;
Hyrich, K. L. ;
Watson, K. D. ;
Lunt, M. ;
Galloway, J. ;
Ustianowski, A. ;
Symmons, D. P. M. .
ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (03) :522-528
[10]   Combination etanercept and methotrexate provides better disease control in very early (≤4 months) versus early rheumatoid arthritis (>4 months and <2 years): post hoc analyses from the COMET study [J].
Emery, Paul ;
Kvien, Tore K. ;
Combe, Bernard ;
Freundlich, Bruce ;
Robertson, Deborah ;
Ferdousi, Tahmina ;
Bananis, Eustratios ;
Pedersen, Ronald ;
Koenig, Andrew S. .
ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (06) :989-992